Anika Therapeutics Inc. (ANIK)
Symbol Info
Listed Symbol ANIK
Name Anika Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $105,531,000
Latest Fiscal EPS $1.28
Price Info
21 Day Moving Average $56.0214
21 Day EMA $55.149110
50 Day Moving Average $51.4498
50 Day EMA $51.805620
200 Day EMA $43.157780
200 Day Moving Average 39.092080
52 Week High $58.93
52 Week Low $29.01
52 Week Change $30.217400
Alpha 0.004398
Beta 1.0254
Standard Deviation 0.110479
R2 0.102400
Periods 60
Share Information
10 Day Average Volume 132,110
20 Day Average Volume 148,340
30 Day Average Volume 162,466
50 Day Average Volume 205,682
Outstanding Shares 13,782,928
Float Shares 13,170,770
Percent Float 95.56%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 332
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 2,305,689
Institute Holdings Percent -
Institute Sold Previous 3 Months 1,081,383
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 612,158
Price Change
7 Day Price Change $-1.2900009
7 Day Percent Change -2.34%
21 Day Price Change $-2
21 Day Percent Change -3.58%
30 Day Price Change $-2.670002
30 Day Percent Change -4.72%
Month To Date Price Change $-2.85
Month To Date Percent -5.02%
90 Day Price Change $13.529999
90 Day Percent Change 33.51%
Quarter To Date $13.290001
Quarter To Date Percent 32.72%
180 Day Price Change $24.539999
180 Day Percent Change 83.55%
200 Day Price Change $20.540000
200 Day Percent Change 61.55%
Year To Date $20.300000
Year To Date Percent 60.40%
Profile
Description Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company's product profile includes Orthobiologics, Dermal, Surgical and other of which Orthobiologics products generates maximum revenue to the company.
Details
Issue Type CS
Market Cap $743,037,648
Sec Type EQS
Auditor Deloitte & Touche LLP
Total Shares Outstanding 13,782,928
CEO Joseph G. Darling
Employees 133
Last Audit UQ
Classification
CIK 0000898437
Industry Biotechnology
Sector Healthcare
NAICS Biological Product (except Diagnostic) Manufacturing(325414)
Info
Address 32 Wiggins Avenue
Bedford, MA 1730
Website http://www.anikatherapeutics.com
Facisimile +1 781 305-9720
Telephone +1 781 457-9000
Email investorrelations@anikatherapeutics.com
Key Ratios
Profitability
EBIT Margin 32.80
EBITDA Margin 38.3
Pre-Tax Profit Margin 44.4
Profit Margin Cont 26.95
Gross Margin 73.00
Profit Margin TOT 26.95
Income Statements
Revenue $108,861,000
Revenue Per Share $7.8982
Revenue 3 Years $2.17
Revenue 5 Years $8.10
Valuation Measures
PE Ratio 28.00
Enterprise Value $669,317,335
Price To Sales 6.825563
Price To Free Cash 25.200000
PE High Last 5 Years 38.0
Price To Book 3.1
Price To Cash Flow 23.4
PE Low Last 5 Years 12.3
Price To Tangible Book 3.4
Financial Strength
Total Debt To Equity 0.1
Int Coverage -
Current Ratio 18.3
Leverage Ratio 1.1
Quick Ratio 15.8
Long Term Debt To Capital 0.08
Assets
Receivables Turnover 4.7
Invoice Turnover 1.30
Assets Turnover 0.40
Management Effectiveness
Return Assets 10.72
Return On Equity 11.91
Return On Capital 10.76
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
ANIK
Anika Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190916 04:35:05